About Harry

Harry Dalton qualified in Medicine in London in 1983. He was awarded a DPhil in mucosal immunology from the University of Oxford in 1992 and elected FRCP in 1998. Dr Dalton has worked as a Clinical Gastroenterologist in Cornwall for over 20 years and has been studying HEV for the past decade. He has written 116 peer-reviewed papers and 40 chapters/reviews, mostly on HEV, including several in high impact journals, including the Lancet, New England Journal of Medicine and Nature Neurology Reviews. Dr Dalton was a panel member on HEV for WHO’s Global Burden of Disease project and advisor to the Food and Drug Administration (safety of blood products), Washington, USA in 2012. He is an external expert advisor to the European Centres of Disease Control and MSF. In 2014 was appointed to the Editorial Board of Journal of Hepatology.

This speaker will be presenting at the following session(s)

  • End of viral hepatitis? Not without tackling hepatitis E!

    Side meeting

    Day: 2 November

    Time: 07:30

    This early morning side meeting will look at this neglected form of the hepatitis virus and the limited strategies to control it. With no efficacious treatment available for acute fulminant hepatitis E and a limited impact from improvements in water and sanitation in displaced populations, this meeting will examine what can be done to limit the burden worldwide. 

    Presentations:

    • Introduction: Hepatitis E in humanitarian settings.
      Iza Ciglenecki,‎ Médecins Sans Frontières
    • Hepatitis E in developing countries: an old disease?
      Dr. Rakesh Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences
    • Hepatitis E in developed countries: a new disease?
      Dr. Harry Dalton, Royal Cornwall Hospitals NHS Trust
    • Hepatitis E vaccine: a new control tool?
      Dr. James Shih, Innovax
    • Round table discussion.
      Moderator: Dr. Harry Dalton, Royal Cornwall Hospitals NHS Trust